+44 (0) 20 7549 9987 | USA callers: +1 212 220 8419

Contact Us Now

Visiongain Publishes Animal Health Market Report 2021-2031

29 January 2021
Pharma

Visiongain has published a new report on Animal Health Market Report 2021-2031: Forecasts by Animal Type (Production Animal (Poultry, Swine, Cattle, Sheep & Goats, Fish), Companion Animal (Dogs, Cats, Horses, Others)), Product (Vaccines (Live Attenuated Vaccines, DNA Vaccines, Recombinant Vaccines, Inactivated Vaccines, Others), Pharmaceuticals (Parasiticides, Anti-Infectives, Anti-Inflammatory, Analgesics, Others), Feed Additives (Nutritional, Medicinal), Diagnostics (Immunodiagnostics (ELISA Tests, Allergen-specific Immunodiagnostic Tests, Immunoassay Analyzers, Others), Molecular Diagnostics (Polymer Chain Reaction Tests, Microarrays, Others), Clinical Biochemistry, Hematology, Urinalysis, Others), Others), Distribution Channel (Retail, E-Commerce, Hospital Pharmacy), End-Use (Reference Laboratories, Point-of-care Testing/In-house Testing, Veterinary Hospitals & Clinics, Others), AND Regional and Leading National Market Analysis PLUS Analysis of Leading Animal Health Companies AND COVID-19 Recovery Scenarios.

The global animal health market is segmented on the basis of region into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to Visiongain analysis, global animal health market is estimated to be valued at US$ xx million in 2020. The market is expected to witness a CAGR of xx% from 2021 to 2026 and is expected to reach US$ xx million in 2026 from its previous value of US$ xx million in 2021. Visiongain further anticipates that the global market will reach US$ xx million in 2031 while growing at a CAGR of xx% from 2021 to 2031.

Which Factors are Fuelling Animal Health Industry Growth?
• Growing Funding in Animal Healthcare Industry
• Branded Generics Boosting Animal Health Market
• Growing Incidence of Zoonotic Diseases
• Rapid Technological Advancements
• Growing Focus on Animal Health

Which Factors are Restraining Animal Health Industry Growth?
• Lack of Standardization
• Increasing Influx of Counterfeit Drugs
• Rising Vaccine Storage Cost

Innovation in Pet Health to Fuel Animal Health Market Growth
The animal health sector is anticipated to evolve at a rapid pace. The veterinary health industry has diverse opportunities to implement new technologies. In veterinary clinics, for example, data generated can be uploaded to the internet for sharing with other clinics and researchers. This can allow for real-time monitoring of changes in disease prevalence. In addition, contact between vets and owners in real time about pet health concerns using mobile online technology is a significant area of development.

Asia Pacific to Witness Highest Growth Rate
Asia Pacific region is expected to experience the highest growth in terms of CAGR over the forecast period owing to growing investments for strengthening the animal healthcare sector by government across economies of China and India. Over the years, animal husbandry in India has undergone magnificent changes thanks to the adoption of innovative technologies for the prevention and treatment of farm animals and their companions. There has been a fundamental change in the market philosophy to animal welfare firms, which has changed from medical to preventive to quality improvement, and now to comprehensive animal health services. The animal welfare sector has developed and driven animal husbandry to unprecedented heights of prominence through modern methods and paradigms.

Competitive Landscape
Some of the companies profiled in the report include Merck Animal Health, SeQuent (Alivira Animal Health Limited), Zoetis, Boehringer Ingelheim GmbH, Elanco, Ceva, Virbac, Vetiquinol S.A., AusDiagnostics Pty, Ltd., Agrolabo S.p.A, BioMérieux SA, Bio-X Diagnostics, Chembio Diagnostic Systems, Inc., Creative Diagnostics, Demedetic Diagnostics GmbH, DRG Diagnostics GmbH, Eurofins Technologies, Eurolyser Diagnostica, Genesig (Primerdesign), Heska Corporation, IDEXX Laboratories, Inc., InBios International, Inc., Neogen Corporation, and Thermo Fisher Scientific, Inc.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.

12 April 2024

Read

Visiongain Publishes Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034

The global Inflammatory Bowel Diseases (IBD) Drugs market was valued at US$27.53 billion in 2023 and is projected to grow at a CAGR of 6.2% during the forecast period 2024-2034.

11 April 2024

Read

Visiongain Publishes Female Health Tech Market Report 2024-2034

The global Female Health Tech market was estimated to be valued at US$ 140.9 billion in 2034 and is expected to register a CAGR of 9.6% from 2024 to 2034.

05 April 2024

Read

Visiongain Publishes Meningococcal Vaccines Market Report 2024-2034

The global Meningococcal Vaccines market is projected to grow at a CAGR of 2.5% by 2034

26 March 2024

Read